A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab - the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project.
Martinelli D et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026